Literature DB >> 28848920

The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.

Maggie Tabberer1, Victoria S Benson1, Heather Gelhorn2, Hilary Wilson2, Niklas Karlsson3, Hana Müllerova1, Shailendra Menjoge4, Stephen I Rennard5,6, Ruth Tal-Singer7, Debora Merrill8, Paul W Jones1,9.   

Abstract

The COPD Biomarkers Qualification Consortium (CBQC) is a public-private partnership formed in 2010 with a goal of qualifying biomarkers and clinical assessment tools for use in clinical or nonclinical decision-making and particularly within the regulatory context. The St George's Respiratory Questionnaire (SGRQ) is a measure of health-related quality of life widely used in clinical research. The aim of the CBQC working group on SGRQ was to construct an individual patient level database of clinical trial data that included the SGRQ, to use this to confirm the reliability and validity of the SGRQ as an outcome measure of health status, and investigate its use as a predictor of future events (exacerbations and mortality). This manuscript describes the formulation of the CBQC database and presents the baseline demographic and clinical characteristics of the integrated SGRQ database overall, and by study type (short-term [≤1 year], medium-term [2-4 years] and observational studies). Distribution of baseline SGRQ scores varied little by demographic determinants except for income region in the observational data set (low-middle income countries +10 units compared with high income, p<0.0001) and this observation held across studies. SGRQ scores increased with increasing modified Medical Research Council dyspnea scores (mean differences ranged 6.9-17.9 units) and with increasing airflow limitations (Global initiative for chronic Obstructive Lung Disease grades 1 to 4; differences ranged 4.5-16.1 units), consistent across study types. As a method of cross-sectional comparison, the SGRQ appears to be relatively free of bias from demographic factors although care should be taken when making cross sectional comparisons of scores between patients in countries at different levels of socio-economic development/.

Entities:  

Keywords:  CBQC; COPD Biomarker Qualification Consortium; SGRQ dataset; St George’s Respiratory Questionnaire; baseline characteristics

Year:  2017        PMID: 28848920      PMCID: PMC5559110          DOI: 10.15326/jcopdf.4.2.2017.0128

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  12 in total

1.  Chronic obstructive pulmonary disease: current burden and future projections.

Authors:  A D Lopez; K Shibuya; C Rao; C D Mathers; A L Hansell; L S Held; V Schmid; S Buist
Journal:  Eur Respir J       Date:  2006-02       Impact factor: 16.671

2.  The COPD Biomarker Qualification Consortium (CBQC).

Authors:  Richard Casaburi; Bartolome Celli; James Crapo; Gerard Criner; Thomas Croxton; Alasdair Gaw; Paul Jones; Nancy Kline-Leidy; David A Lomas; Debora Merrill; Michael Polkey; Stephen Rennard; Frank Sciurba; Ruth Tal-Singer; Robert Stockley; Gerry Turino; Jorgen Vestbo; John Walsh
Journal:  COPD       Date:  2013-06       Impact factor: 2.409

3.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

4.  Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.

Authors:  David M Mannino; Ruth Tal-Singer; David A Lomas; Jorgen Vestbo; R Graham Barr; Kay Tetzlaff; Michael Lowings; Stephen I Rennard; Jeffrey Snyder; Mitchell Goldman; Ubaldo J Martin; Deborah Merrill; Amber L Martin; Jason C Simeone; Kyle Fahrbach; Brian Murphy; Nancy Leidy; Bruce Miller
Journal:  Chronic Obstr Pulm Dis       Date:  2015

5.  Health-related quality of life in patients by COPD severity within primary care in Europe.

Authors:  P W Jones; G Brusselle; R W Dal Negro; M Ferrer; P Kardos; M L Levy; T Perez; J J Soler-Cataluña; T van der Molen; L Adamek; N Banik
Journal:  Respir Med       Date:  2010-10-06       Impact factor: 3.415

Review 6.  Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.

Authors:  Bruce E Miller; Ruth Tal-Singer; Stephen I Rennard; Armin Furtwaengler; Nancy Leidy; Michael Lowings; Ubaldo J Martin; Thomas R Martin; Debora D Merrill; Jeffrey Snyder; John Walsh; David M Mannino
Journal:  Am J Respir Crit Care Med       Date:  2016-03-15       Impact factor: 21.405

7.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

8.  The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium.

Authors:  Bartolome Celli; Kay Tetzlaff; Gerard Criner; Michael I Polkey; Frank Sciurba; Richard Casaburi; Ruth Tal-Singer; Ariane Kawata; Debora Merrill; Stephen Rennard
Journal:  Am J Respir Crit Care Med       Date:  2016-12-15       Impact factor: 21.405

9.  Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire.

Authors:  Makiko Meguro; Elizabeth A Barley; Sally Spencer; Paul W Jones
Journal:  Chest       Date:  2007-07-23       Impact factor: 9.410

10.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

View more
  8 in total

1.  Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.

Authors:  Paul W Jones; Heather Gelhorn; Niklas Karlsson; Shailendra Menjoge; Hana Müllerova; Stephen I Rennard; Ruth Tal-Singer; Hilary Wilson; Debora Merrill; Maggie Tabberer
Journal:  Chronic Obstr Pulm Dis       Date:  2017-03-21

2.  Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.

Authors:  Paul W Jones; Heather Gelhorn; Hilary Wilson; Niklas Karlsson; Shailendra Menjoge; Hana Müllerova; Stephen I Rennard; Ruth Tal-Singer; Debora Merrill; Maggie Tabberer
Journal:  Chronic Obstr Pulm Dis       Date:  2017-03-02

3.  Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials.

Authors:  Paul W Jones; Heather Gelhorn; Hilary Wilson; Victoria S Benson; Niklas Karlsson; Shailendra Menjoge; Hana Müllerova; Stephen I Rennard; Ruth Tal-Singer; Debora Merrill; Maggie Tabberer
Journal:  Chronic Obstr Pulm Dis       Date:  2017-04-01

4.  What's New with the St George's Respiratory Questionnaire and Why Do We Care?

Authors:  Megan Hardin; Stephen I Rennard
Journal:  Chronic Obstr Pulm Dis       Date:  2017-04-03

5.  Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.

Authors:  Hana Müllerová; Mark T Dransfield; Byron Thomashow; Paul W Jones; Stephen Rennard; Niklas Karlsson; Malin Fageras; Norbert Metzdorf; Stefano Petruzzelli; Jean Rommes; Frank C Sciurba; Maggie Tabberer; Debora Merrill; Ruth Tal-Singer
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

6.  Statistical methods for analysis of combined biomarker data from multiple nested case-control studies.

Authors:  Chao Cheng; Abigail Sloan; Molin Wang
Journal:  Stat Methods Med Res       Date:  2021-07-07       Impact factor: 3.021

7.  Relationship of CT densitometry to lung physiological parameters and health status in alpha-1 antitrypsin deficiency: initial report of a centralised database of the NIHR rare diseases translational research collaborative.

Authors:  Diana Crossley; James Stockley; Charlotte E Bolton; Nicholas S Hopkinson; Ravi Mahadeva; Michael Steiner; Tom Wilkinson; John R Hurst; Bibek Gooptu; Robert A Stockley
Journal:  BMJ Open       Date:  2020-06-30       Impact factor: 2.692

8.  Statistical methods for biomarker data pooled from multiple nested case-control studies.

Authors:  Abigail Sloan; Stephanie A Smith-Warner; Regina G Ziegler; Molin Wang
Journal:  Biostatistics       Date:  2021-07-17       Impact factor: 5.899

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.